These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 23279954)
21. [Do psychomotor symptoms predict the treatment response of patients with depressive disorders?]. Rhebergen D; Sienaert P Tijdschr Psychiatr; 2015; 57(2):83-8. PubMed ID: 25669943 [TBL] [Abstract][Full Text] [Related]
22. Structural deficits in the emotion circuit and cerebellum are associated with depression, anxiety and cognitive dysfunction in methadone maintenance patients: a voxel-based morphometric study. Lin WC; Chou KH; Chen HL; Huang CC; Lu CH; Li SH; Wang YL; Cheng YF; Lin CP; Chen CC Psychiatry Res; 2012 Feb; 201(2):89-97. PubMed ID: 22386968 [TBL] [Abstract][Full Text] [Related]
23. [Therapeutic indications in symptomatic cognitive and psychopathological disorders in multiple sclerosis]. Lebrun C Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1085-90. PubMed ID: 11787341 [TBL] [Abstract][Full Text] [Related]
24. Self-referential processing and the prefrontal cortex over the course of depression: a pilot study. Lemogne C; Mayberg H; Bergouignan L; Volle E; Delaveau P; Lehéricy S; Allilaire JF; Fossati P J Affect Disord; 2010 Jul; 124(1-2):196-201. PubMed ID: 19945172 [TBL] [Abstract][Full Text] [Related]
25. Effects of antidepressant drugs on electroencephalography alpha power: importance of study duration. Wiśniewski GS; McAllister-Williams RH; Jakitowicz J; Nowicki Z; Majkowicz M; Trzebiatowska IA Biol Psychiatry; 2008 Nov; 64(10):e5-6; author reply e7. PubMed ID: 18801473 [No Abstract] [Full Text] [Related]
26. Chronic depression: future prospects from recent research. Ferrier IN Int Clin Psychopharmacol; 1991 Jul; 6 Suppl 1():83-9. PubMed ID: 1684591 [TBL] [Abstract][Full Text] [Related]
27. Perspective: Progress on the study and treatment of depressive illness. Carlezon WA; Chartoff E Neuropsychopharmacology; 2009 May; 34(6):1361-2. PubMed ID: 19242407 [No Abstract] [Full Text] [Related]
33. Targeting an old mechanism in a new disease-protection of glutamatergic dysfunction in depression. Sattler R; Rothstein JD Biol Psychiatry; 2007 Jan; 61(2):137-8. PubMed ID: 17223439 [No Abstract] [Full Text] [Related]
34. [Regarding the search for a specific neuropsychological profile in depression: limits and perspectives]. Beblo T; Exner C Neuropsychiatr; 2010; 24(4):234-42. PubMed ID: 21176704 [TBL] [Abstract][Full Text] [Related]
35. [Pharmacologic effects of mechanism of action of antidepressive agents]. Corruble E; Puech AJ Ann Med Psychol (Paris); 1995 May; 153(3):186-9; discussion 189. PubMed ID: 7598352 [No Abstract] [Full Text] [Related]
37. [Indications for new antidepressants with reference to ICD-10: a waggish question or the future of psychiatry?]. De Smet Y Encephale; 1997; 23(2):77-82. PubMed ID: 9264934 [TBL] [Abstract][Full Text] [Related]
38. [Antidepressants for mild depressive disorders]. Baghai TC; Lieb M; Möller HJ; Bschor T; Härter M; Schauenburg H Psychiatr Prax; 2011 Aug; 38(6):270-3. PubMed ID: 21879456 [No Abstract] [Full Text] [Related]